                         SEQUENCE LISTING

<110>  University of Washington through its Center for 
       Commercialization
       PhaseRx, Inc.
       Monahan, S.D.
       Johnson, P.H.
       DeClue, M.S.
       De, P.
       Gall, A.S.
       Stayton, P.S.
       Hoffman, A.S.
 
<120>  TARGETING MONOMERS AND POLYMERS HAVING TARGETING BLOCKS

<130>  UWOTL-1-35874

<150>  US 61/262512
<151>  2009-11-18

<150>  US 61/262516
<151>  2009-11-18

<160>  25    

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified A

<400>  1

Xaa Cys Arg Gly Asp Met Phe Gly Cys Ala 
1               5                   10  


<210>  2
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified G

<400>  2

Xaa Arg Gly Asp Ser Pro 
1               5       


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified C

<400>  3

Xaa Asp Cys Arg Gly Asp Cys Phe Cys 
1               5                   


<210>  4
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified K

<400>  4

Xaa Arg Gly Asp Tyr 
1               5   


<210>  5
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified L

<400>  5

Xaa Arg Gly Asp Asn Leu Ser Asn Ile Asp Tyr Ile Leu Ile Lys Ala 
1               5                   10                  15      


Ser 
    


<210>  6
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified L

<400>  6

Xaa Arg Gly Asp Asn Ser Ala Lys Val Asp Ala Ile Gly Leu Glu Ile 
1               5                   10                  15      


Val 
    


<210>  7
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified L

<400>  7

Xaa Arg Gly Asp Asn Asp Ile Ser Thr Lys Tyr Phe Gln Met Ser Leu 
1               5                   10                  15      


Glu 
    


<210>  8
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified L

<400>  8

Xaa Arg Gly Asp Asn Val Ile Leu Gln Gln Ser Ala Ala Asp Ile Ala 
1               5                   10                  15      


Arg 
    


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified C

<400>  9

Xaa Asp Cys Arg Gly Asp Cys Phe Cys 
1               5                   


<210>  10
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified G

<400>  10

Xaa Arg Gly Asp Asn Pro 
1               5       


<210>  11
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified A

<400>  11

Xaa Cys Asp Cys Arg Gly Asp Cys Phe Cys Gly 
1               5                   10      


<210>  12
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified A

<400>  12

Xaa Cys Asp Cys Arg Gly Asp Cys Phe Cys Gly 
1               5                   10      


<210>  13
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified R

<400>  13

Xaa Gly Asp Asp Phe Lys 
1               5       


<210>  14
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified R

<400>  14

Xaa Gly Asp Phe Lys 
1               5   


<210>  15
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified R

<400>  15

Xaa Gly Asp Phe Lys 
1               5   


<210>  16
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified I

<400>  16

Xaa Cys Arg Arg Ala Arg Gly Asp Asn Pro Asp Asp Arg Cys Thr 
1               5                   10                  15  


<210>  17
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified I

<400>  17

Xaa Cys Arg Arg Ala Arg Gly Asp Asn Pro Asp Asp Arg Cys Thr 
1               5                   10                  15  


<210>  18
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified P

<400>  18

Xaa Leu Ala Glu Ile Asp Gly Ile Glu Leu Thr Tyr 
1               5                   10          


<210>  19
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified H

<400>  19

Xaa Ser Asp Gly Thr Phe Thr Ser Glu Leu Ser Arg Leu Arg Asp Ser 
1               5                   10                  15      


Ala Arg Leu Gln Arg Leu Leu Gln Gly Leu Val 
            20                  25          


<210>  20
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified N

<400>  20

Xaa Pro Val Val Gly Tyr Ile Gly Glu Arg Pro Gln Tyr Arg Asp Leu 
1               5                   10                  15      


<210>  21
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified C

<400>  21

Xaa Thr Thr Thr His Thr Phe Val Lys Ala Leu Thr Met Asp Gly Lys 
1               5                   10                  15      


Gln Ala Ala Trp Arg Phe Ile Arg Ile Asp Thr Ala Cys 
            20                  25                  


<210>  22
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified E

<400>  22

Xaa Leu Tyr Glu Asn Lys Pro Arg Arg Pro Tyr Ile Leu 
1               5                   10              


<210>  23
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified L

<400>  23

Xaa Ser Ile Pro Pro Lys Ala 
1               5           


<210>  24
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified F

<400>  24

Xaa Gln Thr Pro Pro Gln Leu 
1               5           


<210>  25
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is CH2C(CH3)CO-Peg3-CO(CH2)2CO modified L

<400>  25

Xaa Thr Pro Ala Thr Ala Ile 
1               5           


